MCID: ART084
MIFTS: 45

Arteriovenous Fistula

Categories: Cardiovascular diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Arteriovenous Fistula

MalaCards integrated aliases for Arteriovenous Fistula:

Name: Arteriovenous Fistula 38 55

Classifications:



Summaries for Arteriovenous Fistula

MalaCards based summary : Arteriovenous Fistula is related to arteriovenous malformation and arteriovenous malformations of the brain. An important gene associated with Arteriovenous Fistula is EPO (Erythropoietin), and among its related pathways/superpathways are HIF-1-alpha transcription factor network and Lung fibrosis. The drugs Dexmedetomidine and Propofol have been mentioned in the context of this disorder. Affiliated tissues include kidney, endothelial and brain, and related phenotypes are cardiovascular system and immune system

Wikipedia : 76 An arteriovenous fistula is an abnormal connection or passageway between an artery and a vein. It may be... more...

Related Diseases for Arteriovenous Fistula

Diseases in the Arteriovenous Fistula family:

Congenital Systemic Arteriovenous Fistula

Diseases related to Arteriovenous Fistula via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 255)
# Related Disease Score Top Affiliating Genes
1 arteriovenous malformation 31.3 IL6 RASA1
2 arteriovenous malformations of the brain 29.6 IL6 RASA1
3 myelitis 29.3 APOH IL6
4 end stage renal failure 29.3 EPO IL6
5 brain edema 29.3 HMOX1 IL6
6 transverse myelitis 29.2 APOH IL6
7 polyarteritis nodosa 29.2 APOH IL6
8 thrombophilia due to thrombin defect 29.1 APOH PROCR
9 endocarditis 29.0 APOH IL6
10 infective endocarditis 28.9 APOH IL6
11 intermittent claudication 28.8 APOH IL6
12 vascular disease 28.6 APOH HMOX1 IL6
13 pulmonary arteriovenous fistulas 12.2
14 congenital systemic arteriovenous fistula 12.2
15 angiokeratoma corporis diffusum with arteriovenous fistulas 12.2
16 pulmonary arterio-veinous fistula 11.9
17 parkes weber syndrome 11.6
18 dural sinus malformation 11.4
19 klippel-trenaunay-weber syndrome 11.4
20 pulmonary arteriovenous malformation 11.4
21 capillary malformation-arteriovenous malformation 11.4
22 telangiectasia, hereditary hemorrhagic, type 4 11.2
23 aneurysm 10.4
24 thrombosis 10.3
25 cerebritis 10.3
26 cervicitis 10.2
27 coronary artery aneurysm 10.1
28 portal hypertension 10.1
29 hereditary hemorrhagic telangiectasia 10.1
30 paraplegia 10.1
31 weber syndrome 10.1
32 vibrio vulnificus infection 10.1 EPO IL6
33 neonatal jaundice 10.1 HMOX1 IL6
34 acute monoblastic leukemia 10.0 EPO IL6
35 poems syndrome 10.0 EPO IL6
36 fibromuscular dysplasia 10.0
37 periventricular leukomalacia 10.0 EPO IL6
38 diabetic macular edema 10.0 EPO IL6
39 pulmonary hypertension 10.0
40 angiosarcoma 10.0
41 subclavian steal syndrome 10.0
42 dementia 10.0
43 meningitis 10.0
44 brain injury 10.0 EPO IL6
45 neurofibromatosis, type i 9.9
46 neurofibromatosis, type iv, of riccardi 9.9
47 hepatitis 9.9
48 telangiectasis 9.9
49 splenic artery aneurysm 9.9
50 thrombophilia 9.9

Graphical network of the top 20 diseases related to Arteriovenous Fistula:



Diseases related to Arteriovenous Fistula

Symptoms & Phenotypes for Arteriovenous Fistula

MGI Mouse Phenotypes related to Arteriovenous Fistula:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.55 IL6 PROCR RASA1 EPO HMOX1
2 immune system MP:0005387 9.43 IL6 PCNA PROCR RASA1 EPO HMOX1
3 mortality/aging MP:0010768 9.17 PCNA PROCR RASA1 APOH EPO HMOX1

Drugs & Therapeutics for Arteriovenous Fistula

Drugs for Arteriovenous Fistula (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 192)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 68602 5311068
2
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
3
Nitric Oxide Approved Phase 4,Not Applicable 10102-43-9 145068 160954
4
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
5
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 137-58-6 3676
6
Ezetimibe Approved Phase 4 163222-33-1 150311
7
Simvastatin Approved Phase 4 79902-63-9 54454
8
Benzocaine Approved, Investigational Phase 4,Not Applicable 1994-09-7, 94-09-7 2337
9
Clopidogrel Approved Phase 4,Phase 3 120202-66-6, 113665-84-2 60606
10
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
11
Bivalirudin Approved, Investigational Phase 4 128270-60-0 16129704
12
Heparin Approved, Investigational Phase 4,Phase 2,Not Applicable 9005-49-6 772 46507594
13
Tranexamic Acid Approved Phase 4,Phase 2,Phase 3 1197-18-8 5526
14
Nitroglycerin Approved, Investigational Phase 4,Not Applicable 55-63-0 4510
15
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 439542 10909430
16 Fondaparinux Approved, Investigational Phase 4 104993-28-4
17
Ropivacaine Approved Phase 4,Not Applicable 84057-95-4 71273 175805
18
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
19
Iron Approved Phase 4 7439-89-6 23925
20
Amiodarone Approved, Investigational Phase 4 1951-25-3 2157
21
Tetracaine Approved, Vet_approved Phase 4 94-24-6 5411
22
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
23 tannic acid Approved, Nutraceutical Phase 4,Not Applicable
24
Serine Approved, Nutraceutical Phase 4 56-45-1 5951
25
Ergocalciferol Approved, Nutraceutical Phase 4,Not Applicable 50-14-6 5280793
26
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 1406-16-2
27 Adrenergic Agents Phase 4,Not Applicable
28 Adrenergic Agonists Phase 4,Not Applicable
29 Adrenergic alpha-2 Receptor Agonists Phase 4
30 Adrenergic alpha-Agonists Phase 4,Not Applicable
31 Analgesics Phase 4,Not Applicable
32 Analgesics, Non-Narcotic Phase 4,Not Applicable
33 Anesthetics Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1
34 Anesthetics, General Phase 4
35 Anesthetics, Intravenous Phase 4
36 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Not Applicable
37 Hypnotics and Sedatives Phase 4
38 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
39 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Not Applicable
40 Anesthetics, Local Phase 4,Phase 2,Phase 3,Not Applicable
41 Anti-Arrhythmia Agents Phase 4,Phase 3,Phase 2,Not Applicable
42 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Not Applicable
43 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Not Applicable
44 Atorvastatin Calcium Phase 4,Phase 1,Phase 2 134523-03-8
45 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4,Phase 2,Phase 1
46 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3
47 Fibrinolytic Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
48 Platelet Aggregation Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
49 Purinergic P2 Receptor Antagonists Phase 4,Phase 3,Phase 1,Phase 2
50 Purinergic P2Y Receptor Antagonists Phase 4,Phase 3,Phase 1,Phase 2

Interventional clinical trials:

(show top 50) (show all 263)
# Name Status NCT ID Phase Drugs
1 Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery Unknown status NCT02447796 Phase 4 Propofol;Dexmedetomidine
2 Far Infrared Therapy on AV Fistula Flow, Endothelial Function and Echocardiography in ESRD Patients Unknown status NCT01138254 Phase 4
3 2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula Unknown status NCT00993746 Phase 4 Bupivacaine plus lidocaine;Bupivacaine 30 ml
4 Ultrasound Guided Cannulation of Dialysis Fistulas Unknown status NCT01163981 Phase 4
5 Effect of Statins on the Radial Intima-media Thickness After Transradial Angioplasty Unknown status NCT00952770 Phase 4
6 AF Ablation With or Without ROX Coupler Study Unknown status NCT02243891 Phase 4
7 Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy Unknown status NCT01572129 Phase 4 Clopidogrel;Placebo
8 Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI Unknown status NCT00476944 Phase 4
9 Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting Unknown status NCT01572623 Phase 4 Clopidogrel;Atorvastatin
10 Effects of Heparin on Arteriovenous Fistula Patency Completed NCT02493504 Phase 4 Heparin
11 The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas Completed NCT01685710 Phase 4 GTN patch;placebo comparator
12 Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Completed NCT00832611 Phase 4
13 Study of Pain, Anxiety and Complications Related to Cannulation of Arteriovenous (AV) Fistula in Chronic Hemodialysis Patients Completed NCT00544492 Phase 4
14 Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients Completed NCT02106962 Phase 4 Topical Tranexamic Acid 5% with bacitracin
15 Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis Completed NCT00737620 Phase 4
16 A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery Completed NCT01004627 Phase 4
17 AngioSeal Versus Radial Approach in Acute Coronary Syndrome Completed NCT01653587 Phase 4
18 Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation Completed NCT03140631 Phase 4 Protamine Sulfate
19 Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial Completed NCT01389375 Phase 4
20 A Clinical Trial of IntensiVE Dialysis Completed NCT00649298 Phase 4
21 Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) Completed NCT00790907 Phase 4 fondaparinux background and standard dose UFH;Fondaparinux background and low dose heparin;Open label fondaparinux
22 The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery Recruiting NCT03311581 Phase 4 Propofol
23 Vacuumtherapy After Venous Hybrid Procedures Recruiting NCT02905955 Phase 4
24 Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease Recruiting NCT02997046 Phase 4
25 Vascular Closure Device Versus Transradial Approach in Primary Percutaneous Coronary Intervention Recruiting NCT02831166 Phase 4
26 Subcutaneous Nitroglycerin to Facilitate Trans-radial Access. Recruiting NCT03304496 Phase 4 Nitroglycerin 100 MCG/ML Injectable Solution;Saline Solution
27 Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil Recruiting NCT02729740 Phase 4
28 Paricalcitol Improves Anemia of Inflammation Recruiting NCT02876211 Phase 4 Paricalcitol;Epoetin beta;Placebo
29 AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation Recruiting NCT02341105 Phase 4 Amiodarone
30 Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias Terminated NCT01623583 Phase 4
31 ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF Terminated NCT02056938 Phase 4 Anti-Thymocyte Globulins treatment;Basiliximab treatment
32 Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions Terminated NCT02028325 Phase 4 Fluorescein Sodium
33 Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization. Terminated NCT00421252 Phase 4 clopidogrel 600 mg
34 Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze Unknown status NCT01854476 Phase 2, Phase 3
35 Efficacy Study of Assiut Femoral Compression Device Versus Manual Compression in the Achievement of Hemostasis Unknown status NCT02214030 Phase 3
36 First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study) Unknown status NCT00392054 Phase 3 Conventional Antiarrhythmic Drug Therapy
37 Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae Completed NCT01471041 Phase 2, Phase 3
38 Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD Completed NCT02363972 Phase 3
39 Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis Completed NCT03289520 Phase 3 Clopidogrel;Placebo
40 Duplex Guided Application of Local Anesthetic Before Femoral Artery Catheterization Completed NCT00903825 Phase 2, Phase 3
41 Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis Completed NCT01084148 Phase 3 V0034CR01B;V0034CR01B vehicle
42 RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) Trial Completed NCT01446263 Phase 3
43 Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula Recruiting NCT02753998 Phase 3
44 Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Recruiting NCT03183245 Phase 3
45 Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes Recruiting NCT02513303 Phase 3 Sirolimus
46 Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon Recruiting NCT02565953 Phase 3
47 Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders and Previously Untreatable Patients (SOLVE CRT) Recruiting NCT02922036 Phase 3
48 Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae Active, not recruiting NCT02440022 Phase 3
49 A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2) Active, not recruiting NCT02414841 Phase 3 vonapanitase;Placebo
50 A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1) Active, not recruiting NCT02110901 Phase 3 PRT-201;Placebo

Search NIH Clinical Center for Arteriovenous Fistula

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Arteriovenous Fistula cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Arteriovenous Fistula:
VASCUGEL
Embryonic/Adult Cultured Cells Related to Arteriovenous Fistula:
Aortic endothelial cells cultured in matrix (VASCUGEL PMIDs: 7667257
Aortic endothelial cells cultured in matrix PMIDs: 7667257

Genetic Tests for Arteriovenous Fistula

Anatomical Context for Arteriovenous Fistula

MalaCards organs/tissues related to Arteriovenous Fistula:

41
Kidney, Endothelial, Brain, Testes, Heart, Spinal Cord, Liver

Publications for Arteriovenous Fistula

Articles related to Arteriovenous Fistula:

(show top 50) (show all 585)
# Title Authors Year
1
Erratum Regarding "Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study" (Am J Kidney Dis. 2018;71[6]:793-801). ( 29960796 )
2018
2
Conus Medullaris Dural Arteriovenous Fistula Arising From the Artery of the Filum Terminale: 2-Dimensional Operative Video. ( 29444295 )
2018
3
Association of Preoperative Mean Arterial Pressure With the Primary Failure of Brescia-Cimino Arteriovenous Fistula Within the First 7 Days Following Surgery in Hemodialysis Patients. ( 29923672 )
2018
4
Giant arachnoid granulation with a thrombosed dural arteriovenous fistula. ( 29950364 )
2018
5
Omega-3 Polyunsaturated Fatty Acid Supplementation toA Prevent Arteriovenous Fistula and Graft Failure: AA Systematic Review and Meta-analysis of RandomizedA Controlled Trials. ( 29395485 )
2018
6
Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: AA NationalA Study. ( 29429750 )
2018
7
A rare cause of cyanosis in newborns: arteriovenous fistula between the right pulmonary artery and the left atrium and its treatment. ( 29362005 )
2018
8
Glucose pump test can be used to measure blood flow rate of native arteriovenous fistula in chronic hemodialysis. ( 29411718 )
2018
9
Successful Surgical Remodeling of a Giant Venous Aneurysm Formed in an Autogenous Arteriovenous Fistula: A Case Report. ( 29946222 )
2018
10
A Case of Dural Arteriovenous Fistula Mimicking a Cerebellar Tumor. ( 29977449 )
2018
11
Simultaneous transarterial and transvenous coil embolization for a large aneurysmal-type renal arteriovenous fistula. ( 29904500 )
2018
12
Paraplegia following lumbar puncture: a rare complication in spinal dural arteriovenous fistula. ( 29808310 )
2018
13
Regarding "A novel technique for duplex-guided office-based interventions for patients with acute arteriovenous fistula occlusion". ( 29937036 )
2018
14
Dural arteriovenous fistula between the inferolateral trunk and cavernous sinus draining to the ophthalmic vein: a case report. ( 29940382 )
2018
15
Prenatal diagnosis of isolated coronary arteriovenous fistula. ( 29372164 )
2018
16
Vertebral Arteriovenous Fistula: A Rare Complication Following Transpedicular Occipitocervical Fixation in a Patient with Atlantoaxial Dislocation. ( 29966140 )
2018
17
Spinal dural arteriovenous fistula: delay to radiological diagnosis and sources of radiological error. ( 29898828 )
2018
18
Pulmonary arteriovenous fistula complicated by venous thromboembolism and paradoxical cerebral infarction during early pregnancy. ( 29437680 )
2018
19
Choice of a second vascular access in hemodialysis patients whose initial arteriovenous fistula failed to mature. ( 29937290 )
2018
20
Unanticipated late maturation of an arteriovenous fistula after creation of separate graft access. ( 29928609 )
2018
21
Polymorphism in dural arteriovenous fistula: Matrix Metalloproteinase-2-1306 C/T as a potential risk factor for sinus thrombosis. ( 29431912 )
2018
22
Temporal evolution of a patient with a spinal dural arteriovenous fistula on serial MRI. ( 29423315 )
2018
23
Efficacy and comparison of elevation transposition and lipectomy for superficialization of cephalic arteriovenous fistula veins. ( 29926786 )
2018
24
Frequency and characteristics associated with inherited thrombophilia in patients with intracranial dural arteriovenous fistula. ( 29624150 )
2018
25
Letter to the Editor. Steroid administration in Cognard type V dural arteriovenous fistula. ( 29393812 )
2018
26
Electrocardiographic artifact due to an arteriovenous fistula. ( 29933853 )
2018
27
Pial arteriovenous fistula of the spine in a child with hemiplegia. ( 29881582 )
2018
28
Reversible Cerebral Vasoconstriction Syndrome as an Unusual Complication of a Dural Arteriovenous Fistula treated with Onyx Embolization. ( 29751188 )
2018
29
Unique percutaneous direct puncture technique for occlusion of a hypoglossal canal dural arteriovenous fistula. ( 29909379 )
2018
30
Recurring thalamic symptoms due to intracranial dural arteriovenous fistula: a report of an unusual case and its treatment outcome. ( 29969738 )
2018
31
A systematic review and meta-analysis of one-stage versus two-stage brachiobasilic arteriovenous fistula creation. ( 29937034 )
2018
32
Intraosseous venous structures adjacent to the jugular tubercle associated with an anterior condylar dural arteriovenous fistula. ( 29411060 )
2018
33
Varicocele Due to Post Traumatic Arteriovenous Fistula. ( 29432872 )
2018
34
Dural arteriovenous fistula presenting with acute subdural haematoma showing impending cerebral herniation. ( 29950494 )
2018
35
Isolated intraventricular hemorrhage secondary to dural arteriovenous fistula. ( 29437717 )
2018
36
Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: AA Multicenter Prospective Cohort Study. ( 29398178 )
2018
37
Determinants of patency of arteriovenous fistula in hemodialysis patients. ( 29970738 )
2018
38
Iatrogenic subclavian arteriovenous fistula during permanent pacemaker implantation: Closed by endovascular coiling. ( 29951155 )
2018
39
Letter: Transarterial N-Butyl-2-cyanoacrylate Embolization of an Intraosseous Dural Arteriovenous Fistula Associated With Acute Epidural Hematoma: Technical Case Report. ( 28927216 )
2017
40
Dialysis Arteriovenous Fistula Failure and Angioplasty: IntimalA Hyperplasia and Other Causes of Access Failure. ( 28084215 )
2017
41
Arteriovenous Fistula: an Uncommon Cause of Heart Failure. ( 28916421 )
2017
42
End-To-Side Versus Side-To-Side Anastomosis In Upper Limb Arteriovenous Fistula For Dialysis Access: A Systematic Review And A Meta-Analysis. ( 28916306 )
2017
43
Platelet-rich gel for the adjuvant treatment of wound healing of transposed flap for arteriovenous fistula in systemic scleroderma. ( 28058708 )
2017
44
Endovascular treatment of a dural arteriovenous fistula in a patient with Loeys-Dietz syndrome: A case report. ( 28304197 )
2017
45
Endophlebectomy of the common femoral vein and arteriovenous fistula creation as adjuncts to venous stenting for post-thrombotic syndrome. ( 28221670 )
2017
46
De Novo Spinal Dural Arteriovenous Fistula (AVF) in a Patient with a Lipomyelomeningocele: A Case Report. ( 29253691 )
2017
47
Brain Abscesses Associated with Asymptomatic Pulmonary Arteriovenous Fistulas. ( 28061502 )
2017
48
Pial Arteriovenous Fistula and Capillary Malformation-Arteriovenous Malformation Associated with RASA1 Mutation: 2 Pediatric Cases with Successful Surgical Management. ( 28558378 )
2017
49
Traumatic arteriovenous fistula of the vertebral artery. ( 28089445 )
2017
50
Resolution of reactive angioendotheliomatosis in an arteriovenous fistula with innominate vein angioplasty. ( 29192720 )
2017

Variations for Arteriovenous Fistula

Expression for Arteriovenous Fistula

Search GEO for disease gene expression data for Arteriovenous Fistula.

Pathways for Arteriovenous Fistula

Pathways related to Arteriovenous Fistula according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.25 EPO HMOX1
2 11.2 HMOX1 IL6
3 11.05 EPO IL6
4 11 EPO IL6
5 10.8 HMOX1 IL6
6 10.8 EPO HMOX1 IL6
7 10.69 HMOX1 IL6
8 10.23 HMOX1 IL6

GO Terms for Arteriovenous Fistula

Biological processes related to Arteriovenous Fistula according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.48 EPO IL6
2 response to estrogen GO:0043627 9.46 EPO HMOX1
3 cellular response to hydrogen peroxide GO:0070301 9.43 IL6 PCNA
4 positive regulation of smooth muscle cell proliferation GO:0048661 9.4 HMOX1 IL6
5 positive regulation of DNA replication GO:0045740 9.37 EPO PCNA
6 regulation of angiogenesis GO:0045765 9.32 HMOX1 IL6
7 acute-phase response GO:0006953 9.26 EPO IL6
8 liver regeneration GO:0097421 9.16 HMOX1 PCNA
9 response to dexamethasone GO:0071548 8.96 EPO PCNA
10 negative regulation of myeloid cell apoptotic process GO:0033033 8.62 APOH EPO

Sources for Arteriovenous Fistula

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....